Sahpolat, M. Et Al. 2021. Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients. Clinical Psychopharmacology and Neuroscience , vol.19, no.1 , 112-116.

Sahpolat, M., Ayar, D., Ari, M., & Karaman, M. A., (2021). Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients. Clinical Psychopharmacology and Neuroscience , vol.19, no.1, 112-116.

Sahpolat, Musa Et Al. "Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients," Clinical Psychopharmacology and Neuroscience , vol.19, no.1, 112-116, 2021

Sahpolat, Musa Et Al. "Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients." Clinical Psychopharmacology and Neuroscience , vol.19, no.1, pp.112-116, 2021

Sahpolat, M. Et Al. (2021) . "Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients." Clinical Psychopharmacology and Neuroscience , vol.19, no.1, pp.112-116.

@article{article, author={Musa Sahpolat Et Al. }, title={Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients}, journal={Clinical Psychopharmacology and Neuroscience}, year=2021, pages={112-116} }